Cargando…

Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas

Sarcomas are a heterogenous group of malignant tumors with origin or mesenchymal differentiation, they comprise 1–2% of all solid tumors. Retroperitoneum is the second most frequent site affected. Prognosis is worse compared to the limbs, with a 5y OS of 36–58%, and 50–60% patients will relapse. Ded...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorian Yarih, Garcia-Ortega, Claudia HS, Caro-Sánchez, Alethia, Alvarez-Cano, Mario, Alvarez-Bojorquez, Emmanuel, Melgarejo-Estefan, Ernesto, Rodríguez-Ayala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919200/
https://www.ncbi.nlm.nih.gov/pubmed/33738084
http://dx.doi.org/10.1177/2036361320986655
_version_ 1783658088457306112
author Dorian Yarih, Garcia-Ortega
Claudia HS, Caro-Sánchez
Alethia, Alvarez-Cano
Mario, Alvarez-Bojorquez
Emmanuel, Melgarejo-Estefan
Ernesto, Rodríguez-Ayala
author_facet Dorian Yarih, Garcia-Ortega
Claudia HS, Caro-Sánchez
Alethia, Alvarez-Cano
Mario, Alvarez-Bojorquez
Emmanuel, Melgarejo-Estefan
Ernesto, Rodríguez-Ayala
author_sort Dorian Yarih, Garcia-Ortega
collection PubMed
description Sarcomas are a heterogenous group of malignant tumors with origin or mesenchymal differentiation, they comprise 1–2% of all solid tumors. Retroperitoneum is the second most frequent site affected. Prognosis is worse compared to the limbs, with a 5y OS of 36–58%, and 50–60% patients will relapse. Dedifferentiated liposarcomas (ddLPS) are more aggressive, it is known that presence of a de-differentiated component increases the probability of distant recurrence and lowers OS. There is little information about the specific impact of each type of de-differentiation. To determine if the presence of myogenic differentiation markers in DDLPS is an adverse prognostic factor. A retrospective, observational, analytic cohort study was performed. Cases identified from the electronic clinical files from the National Cancer Institute in Mexico City, we included cases from January 1st 2005 to December 31st 2016. We correlated the presence of expression of myogenic markers (Smooth muscle actin, Calponin, H-caldesmon, Desmin and Myogenin) in the dedifferentiated component of DDLPS with overall survival and surgical outcomes. One hundred and forty-three cases were analyzed. Eighty-two were liposarcomas, and 38 had a dedifferentiated component. Of these 38 cases, 21(55.3%) were males and, 17(44.7%) were females. Median age was 54.1(27–79) years, median tumor size was 28 cm (13–56). Most patients had locally advanced disease: 32(84.2%) were in stage IIIB. 2.6% had metastatic disease and 5(13.2%) had stage Ib at diagnosis. Myogenic marker expression was found in 18.4% of cases; these patients had a worse median survival than cases with no myogenic expression: 18 months (95% CI 15.4–20.5) vs 32 months (95% CI 21.8–42.1) p = 0.01, we also found a relation with higher postoperative morbidity in these cases (p = 0.045). The presence of myogenic differentiation markers might be associated with a worse prognosis, in our series it corelated with worse OS, however it is not a common event. Relation with surgical morbidity is to be analyzed in further studies.
format Online
Article
Text
id pubmed-7919200
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-79192002021-03-17 Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas Dorian Yarih, Garcia-Ortega Claudia HS, Caro-Sánchez Alethia, Alvarez-Cano Mario, Alvarez-Bojorquez Emmanuel, Melgarejo-Estefan Ernesto, Rodríguez-Ayala Rare Tumors Original Article Sarcomas are a heterogenous group of malignant tumors with origin or mesenchymal differentiation, they comprise 1–2% of all solid tumors. Retroperitoneum is the second most frequent site affected. Prognosis is worse compared to the limbs, with a 5y OS of 36–58%, and 50–60% patients will relapse. Dedifferentiated liposarcomas (ddLPS) are more aggressive, it is known that presence of a de-differentiated component increases the probability of distant recurrence and lowers OS. There is little information about the specific impact of each type of de-differentiation. To determine if the presence of myogenic differentiation markers in DDLPS is an adverse prognostic factor. A retrospective, observational, analytic cohort study was performed. Cases identified from the electronic clinical files from the National Cancer Institute in Mexico City, we included cases from January 1st 2005 to December 31st 2016. We correlated the presence of expression of myogenic markers (Smooth muscle actin, Calponin, H-caldesmon, Desmin and Myogenin) in the dedifferentiated component of DDLPS with overall survival and surgical outcomes. One hundred and forty-three cases were analyzed. Eighty-two were liposarcomas, and 38 had a dedifferentiated component. Of these 38 cases, 21(55.3%) were males and, 17(44.7%) were females. Median age was 54.1(27–79) years, median tumor size was 28 cm (13–56). Most patients had locally advanced disease: 32(84.2%) were in stage IIIB. 2.6% had metastatic disease and 5(13.2%) had stage Ib at diagnosis. Myogenic marker expression was found in 18.4% of cases; these patients had a worse median survival than cases with no myogenic expression: 18 months (95% CI 15.4–20.5) vs 32 months (95% CI 21.8–42.1) p = 0.01, we also found a relation with higher postoperative morbidity in these cases (p = 0.045). The presence of myogenic differentiation markers might be associated with a worse prognosis, in our series it corelated with worse OS, however it is not a common event. Relation with surgical morbidity is to be analyzed in further studies. SAGE Publications 2021-02-26 /pmc/articles/PMC7919200/ /pubmed/33738084 http://dx.doi.org/10.1177/2036361320986655 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Dorian Yarih, Garcia-Ortega
Claudia HS, Caro-Sánchez
Alethia, Alvarez-Cano
Mario, Alvarez-Bojorquez
Emmanuel, Melgarejo-Estefan
Ernesto, Rodríguez-Ayala
Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
title Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
title_full Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
title_fullStr Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
title_full_unstemmed Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
title_short Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
title_sort myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919200/
https://www.ncbi.nlm.nih.gov/pubmed/33738084
http://dx.doi.org/10.1177/2036361320986655
work_keys_str_mv AT dorianyarihgarciaortega myogenicdedifferentiationisassociatedwithpooroutcomesinretroperitonealdedifferentiatedliposarcomas
AT claudiahscarosanchez myogenicdedifferentiationisassociatedwithpooroutcomesinretroperitonealdedifferentiatedliposarcomas
AT alethiaalvarezcano myogenicdedifferentiationisassociatedwithpooroutcomesinretroperitonealdedifferentiatedliposarcomas
AT marioalvarezbojorquez myogenicdedifferentiationisassociatedwithpooroutcomesinretroperitonealdedifferentiatedliposarcomas
AT emmanuelmelgarejoestefan myogenicdedifferentiationisassociatedwithpooroutcomesinretroperitonealdedifferentiatedliposarcomas
AT ernestorodriguezayala myogenicdedifferentiationisassociatedwithpooroutcomesinretroperitonealdedifferentiatedliposarcomas